Dr. Teitel obtained his MD degree and pursued residency training at the University of Toronto. He was a research fellow at Harvard University, under the supervision of Dr. Robert Rosenberg, where he worked on novel radioimmunoassay for the detection of coagulation activation.

Dr. Teitel is a Professor of Medicine at the University of Toronto, and the Division Head of Hematology and Oncology at St. Michael’s Hospital, a fully-affiliated teaching hospital. He is Medical Director of the Hemophilia Comprehensive Care Program, and of the clinical Program in Specialized Complex Care. He is President of the Canadian Hematology Society, and is past President of both the Association of Hemophilia Clinic Directors of Canada (AHCDC) and of the Hemophilia and Thrombosis Research Society of North America (HTRS). His publications have focused on hemophilia and related disorders of hemostasis and thrombosis.

Back to Executive Commitee